COMMUNIQUÉS West-GlobeNewswire

Paratek’s NUZYRA™ (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market
08/05/2019
-- Approximately One Third of Commercial Lives in U.S. had Access to NUZYRA by the End of the First Quarter 2019 -- -- Significant Presence at ECCMID 2019 with Nine NUZYRA Presentations -- BOSTON, May 08, 2019 (GLOBE [...]
Dynavax Announces First Quarter 2019 Financial Results
08/05/2019
First quarter 2019 HEPLISAV-B® net product revenue of $5.6 million Conference call to be held today at 4:30 p.m. ET/1:30 p.m. PT BERKELEY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation ( [...]
OrthoPediatrics Corp. Reports First Quarter 2019 Financial Results
08/05/2019
First Quarter 2019 Revenue Increased 21.2% Year-over-Year to $14.7 Million WARSAW, Ind., May 08, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), an orthopedic company focused [...]
Precision Optics Corporation Schedules Third Quarter Conference Call
08/05/2019
GARDNER, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 third quarter [...]
Sienna Biopharmaceuticals Reports First Quarter 2019 Financial Results
08/05/2019
-- Company Completed Positive End-of-Phase 2 Meeting with FDA for SNA-120 in Psoriasis WESTLAKE VILLAGE, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) today reported the Company’ [...]
Akcea Reports Financial Results and Highlights for First Quarter 2019
08/05/2019
Achieved First Quarter 2019 TEGSEDI ® (inotersen) Global Net Product Revenues of $7 Million Novartis exercised its option to license AKCEA-APO(a)-L Rx Received marketing authorization for WAYLIVRA ® (volanesorsen) in E. [...]
GBT Reports Recent Business Progress and First Quarter 2019 Financial Results
08/05/2019
SOUTH SAN FRANCISCO, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the first quarter ended March 31, 2019 [...]
Sienna Senior Living Inc. Reports 2019 First Quarter Financial Results
08/05/2019
MARKHAM, Ontario, May 08, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three months ended March 31, 2019. The Unaudited [...]
Sarepta Therapeutics Announces First Quarter 2019 Financial Results and Recent Corporate Developments
08/05/2019
CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the three months ended March [...]
Avid Bioservices Names Richard B. Hancock as Interim President and Chief Executive Officer
08/05/2019
Industry Veteran with Over 30 Years of Operational and Executive Experience Succeeds Roger J. Lias, Ph.D. TUSTIN, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated [...]
CV Sciences, Inc. Reports First Quarter 2019 Financial Results
08/05/2019
Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”) announced today its financial [...]
Novavax Announces Reverse Stock Split of Common Stock
08/05/2019
GAITHERSBURG, Md., May 08, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will effect a one-for-twenty reverse stock split of its issued and outstanding common stock. Stockholders of Novavax [...]
SI-BONE, Inc. Reports First Quarter 2019 Financial Results
08/05/2019
SANTA CLARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for [...]
Intercept Pharmaceuticals Announces Proposed Offerings of $200 Million of Common Stock and $200 Million of Convertible Senior Notes due 2026
08/05/2019
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral [...]
The Joint Corp. to Participate in Upcoming Investor Conferences
08/05/2019
SCOTTSDALE, Ariz., May 08, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management plans to present and conduct one-on-one [...]
Scholar Rock Announces Initiation of Patient Dosing in Phase 2 Trial of SRK-015 in Spinal Muscular Atrophy
08/05/2019
Dosing of patients has commenced in TOPAZ, the Phase 2 clinical trial of SRK-015 in Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Preliminary PK/PD data from a subset of patients are anticipated by year-end 2019 [...]
Shockwave Medical Reports First Quarter 2019 Financial Results
08/05/2019
SANTA CLARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
T2 Biosystems to Showcase Breakthrough Rapid Diagnostics During 22nd Annual MAD-ID Meeting in Orlando, Florida
08/05/2019
Company will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panels—can be implemented into antimicrobial stewardship programs LEXINGTON, Mass., May 08, 2019 (GLOBE NEWSWIRE [...]
CellaVision AB: Bulletin from AGM held on May 8, 2019
08/05/2019
Annual General Meeting of CellaVision AB (publ) on May 8, 2019 The information was submitted to the public on May 8, 2019 at 20:30 CellaVision AB (publ) held the Annual General Meeting on May 8, 2019 at the company's [...]

Pages